Compare Tyche Industries with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of -8.35% and Operating profit at -49.08% over the last 5 years
With a fall in PBT of -24.42%, the company declared Very Negative results in Dec 25
With ROE of 4.8, it has a Very Expensive valuation with a 0.8 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 110 Cr (Micro Cap)
16.00
36
2.83%
-0.19
4.77%
0.77
Total Returns (Price + Dividend) 
Latest dividend: 3 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate sharply, with its price-to-earnings (P/E) ratio and price-to-book value (P/BV) signalling a shift from expensive to very expensive territory. This re-rating comes amid subdued financial performance and a challenging sector backdrop, raising concerns about the stock’s price attractiveness relative to peers and historical benchmarks.
Read full news article
Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Challenges
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change accompanies a downgrade in its Mojo Grade to Strong Sell, reflecting growing concerns over its price attractiveness relative to historical and peer benchmarks.
Read full news article
Tyche Industries Ltd is Rated Strong Sell
Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article Announcements 
Disclosures Under Reg. 10(6) Of SEBI (SAST) Regulations 2011
20-Mar-2026 | Source : BSEDisclosure under Regulation 10(6) of SEBI(Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
20-Mar-2026 | Source : BSEEnclosed the Disclosure under Regulation 10(6) of SEBI(SAST) Regulations 2011
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
20-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar
Corporate Actions 
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Silver Oak Technologies Private Limited (19.31%)
Plutus Techlabs Private Limited (6.4%)
26.51%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -25.28% vs 11.50% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 19.74% vs -37.45% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024
Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024
YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024






